← Upcoming Courses
This highly interactive and engaging virtual training session will focus on two critical areas of patient care: hypertension and type 2 diabetes. Led by seasoned and highly experienced clinicians from the fields of cardiology and endocrinology, this event offers a platform for participants to gain valuable insights into optimizing patient outcomes through evidence-based approaches. The event will feature two in-depth presentations—one on hypertension and the other on the metabolic benefits of DPP4 inhibitors in managing type 2 diabetes. Each session will include a Q&A to encourage participant interaction and real-time feedback from the facilitators.
WHY YOU SHOULD REGISTER AND JOIN
Healthcare professionals specializing in the management of cardiovascular and metabolic diseases face evolving challenges, from medication choices to patient adherence. This training event provides an opportunity to stay updated on the latest treatment strategies. With expert facilitators guiding the discussions, you will gain deeper insights into the clinical application of ARBs for hypertension and DPP4 inhibitors for diabetes management, all with a focus on improving patient outcomes. The interactive format ensures that your questions and clinical concerns are addressed in real time, allowing for a personalized learning experience. Don't miss out on this opportunity to refine your skills and enhance your practice.
FOCUS PRODUCT: Trajenta
As part of the session, we will explore the metabolic benefits of DPP4 inhibitors in the treatment of type 2 diabetes, with particular attention to Trajenta. Trajenta (linagliptin) offers a clinically proven option for glycemic control without the concern of dose adjustment for renal impairment. This discussion will be embedded within a broader context of diabetes management, ensuring that participants leave with a balanced, patient-centered understanding of the therapeutic landscape.
ORGANIZED BY
This is virtual event will take place on Wednesday the 9th of October 2024 at 16:00 GMT.
Target Audience: Physicians, Family Physicians, General Practitioners, Residents, Specialists
Moderator: Pharm Jonah Asante (Representative, Boehringer Ingelheim)
Date: Wednesday, 9th October 2024
Time: 16:00 GMT (4:00 PM Local Time)
AGENDA
Virtual Event – Wednesday, 9th October 2024
16:00 – 16:10 | Meeting Opening & Introduction of Speakers
Pharm Jonah Asante
Representative, Boehringer Ingelheim
16:10 – 16:55 | Presentation: The Metabolic Benefits of DPP4 Inhibitors in the Management of Type 2 Diabetes
Dr. Ebenezer Nikoi
Endocrinologist, Korle Bu Teaching Hospital (KBTH)
16:55 – 17:40 | Presentation: Optimizing Hypertension Management – The Role of ARBs for Improved Patient Outcomes
Dr. Mrs. Desrie Delsol-Gyan
Consultant Cardiologist, National Cardiothoracic Centre
17:40 – 17:55 | Q&A Session
Dr. Ebenezer Nikoi & Dr. Mrs. Desrie Delsol-Gyan
17:55 – 18:00 | Closing Remarks
Pharm Jonah Asante
Representative, Boehringer Ingelheim
Note: The event will feature interactive Q&A sessions with the facilitators, providing opportunities for real-time engagement and discussion.
Overview
Course Description
This highly interactive and engaging virtual training session will focus on two critical areas of patient care: hypertension and type 2 diabetes. Led by seasoned and highly experienced clinicians from the fields of cardiology and endocrinology, this event offers a platform for participants to gain valuable insights into optimizing patient outcomes through evidence-based approaches. The event will feature two in-depth presentations—one on hypertension and the other on the metabolic benefits of DPP4 inhibitors in managing type 2 diabetes. Each session will include a Q&A to encourage participant interaction and real-time feedback from the facilitators.
What you will learn
By the end of the event, participants will be able to:
1. Discuss the role of ARBs in optimizing the management of hypertension.
2. Evaluate the clinical advantages of DPP4 inhibitors, particularly in patients with type 2 diabetes.
3. Identify strategies for integrating these therapeutic options into individualized patient care plans.
4. Understand the impact of metabolic control on cardiovascular risk in diabetic patients.
5. Apply the latest evidence-based approaches to improve long-term patient outcomes.
Course Content
Lecture Sessions
- LIVE EVENT: Premiering on Wednesday, 9th October, 2024 @ 1600 GMT (4:00 pm) 2 hours
Downloadables
No downloadable content added to this course yet.
About Facilitators
- 4 Courses on CES
Dr. Desrie Delsol-Gyan
MD, FGCP
Consultant Cardiologist, Adjunct Senior Lecturer
The National Cardiothoracic Centre - Korle-Bu Teaching Hospital, Accra, Ghana
School of Medicine, the University of Health and Allied Sciences - UHAS, Ho, Ghana
Dr. Desrie Delsol-Gyan currently holds the esteemed position of Consultant Cardiologist at the National Cardiothoracic Centre in Korle Bu, a role she has undertaken since April 2015.
View full profile / courses
- 1 Course on CES
Dr. Ebenezer Nii Ashalley Nikoi
BSc, MBChB, MSc, MGCP, FWACP
Senior Physician Specialist and Endocrinologist
Korle-Bu Teaching Hospital, Accra, Ghana.
Dr. Ebenezer Nii Ashalley Nikoi is a self-motivated and goal-oriented senior physician specialist and endocrinologist, recognized for his excellent communication, interpersonal, and problem-solving skills.
View full profile / courses
